[go: up one dir, main page]

PE20071153A1 - DERMOPARMACEUTIC COMPOSITION INCLUDING CURCUMA LONGA EXTRACT - Google Patents

DERMOPARMACEUTIC COMPOSITION INCLUDING CURCUMA LONGA EXTRACT

Info

Publication number
PE20071153A1
PE20071153A1 PE2007000401A PE2007000401A PE20071153A1 PE 20071153 A1 PE20071153 A1 PE 20071153A1 PE 2007000401 A PE2007000401 A PE 2007000401A PE 2007000401 A PE2007000401 A PE 2007000401A PE 20071153 A1 PE20071153 A1 PE 20071153A1
Authority
PE
Peru
Prior art keywords
curcuma longa
dermoparmaceutic
composition including
longa extract
composition
Prior art date
Application number
PE2007000401A
Other languages
Spanish (es)
Inventor
Marie-Christine Seguin
Original Assignee
Exsymol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exsymol Sa filed Critical Exsymol Sa
Publication of PE20071153A1 publication Critical patent/PE20071153A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) EXTRACTO DE CURCUMA LONGA QUE SE ENCUENTRA EN UNA CANTIDAD DE 1% A 10% EN PESO DE LA COMPOSICION, EL CUAL COMPRENDE DERIVADOS FLAVONOIDES Y FENILPROPANOIDES QUE REDUCEN O INHIBEN LA METABOLIZACION DE LA TESTOSTERONA; B) UREA; C) NG-NITRO-L-ARGININA METIL ESTER. DICHA COMPOSICION ESTA FORMULADA COMO CREMA, GEL, TABLETAS, SIENDO UTIL PARA EL TRATAMIENTO DE ALOPECIA MASCULINA, HIPERSEBORREA, DISMINUCION DE CRECIMIENTO DE PELOS NO DESEADOS EN LA CARAIT REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES: A) CURCUMA LONGA EXTRACT WHICH IS IN AN AMOUNT OF 1% TO 10% BY WEIGHT OF THE COMPOSITION, WHICH INCLUDES FLAVONOID DERIVATIVES AND PHENYLPROPROPANOIDESTERIBENESS WHICH REDUCE OR INHIBITED TENYLPROPROPANOIDESTERIBESTIBENOSTERIA B) UREA; C) NG-NITRO-L-ARGININE METHYL ESTER. SUCH COMPOSITION IS FORMULATED AS A CREAM, GEL, TABLETS, BEING USEFUL FOR THE TREATMENT OF MALE ALOPECIA, HYPEREBORRHEA, REDUCTION OF UNWANTED HAIR GROWTH ON THE FACE

PE2007000401A 2006-04-03 2007-04-03 DERMOPARMACEUTIC COMPOSITION INCLUDING CURCUMA LONGA EXTRACT PE20071153A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MC2517A MC200087A1 (en) 2006-04-03 2006-04-03 Turmeric longa extract and its cosmetic or dermopharmaceutical applications

Publications (1)

Publication Number Publication Date
PE20071153A1 true PE20071153A1 (en) 2008-02-06

Family

ID=37603672

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000401A PE20071153A1 (en) 2006-04-03 2007-04-03 DERMOPARMACEUTIC COMPOSITION INCLUDING CURCUMA LONGA EXTRACT

Country Status (4)

Country Link
CO (1) CO5960127A1 (en)
MC (1) MC200087A1 (en)
MX (1) MX2007004110A (en)
PE (1) PE20071153A1 (en)

Also Published As

Publication number Publication date
MC200087A1 (en) 2006-11-02
CO5960127A1 (en) 2008-09-30
MX2007004110A (en) 2009-02-16

Similar Documents

Publication Publication Date Title
MX2009000147A (en) SPRAY FORMULATIONS IN AEROSOL.
MX2010007011A (en) Composition for human and/or animal nutrition, uses thereof and yeasts.
UA94942C2 (en) Dpp iv inhibitor formulations
CY1119968T1 (en) COMPOSITIONS OF INNOVATIVE COSMETIC AND / OR PHARMACEUTICAL PRODUCTS AND THEIR USES
CL2008003582A1 (en) Use of a pharmaceutical composition containing cysteamine or cystamine in the preparation of a useful medicine for the treatment of non-alcoholic fatty liver disease (nafld) or non-alcoholic steatohepatitis (nash).
WO2007141392A3 (en) Compositions comprising betulonic acid
CL2012002742A1 (en) Stable aqueous alkali metal silicate composition comprising an osmolyte; use of said composition to protect crops or to prepare pharmaceutical or cosmetic composition or a food or food supplement.
AR064614A1 (en) PRODUCT COMBINED TO CONTROL PARASITES IN ANIMALS
UY30215A1 (en) CHROMANOL DERIVATIVES REPLACED, PROCEDURES FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
AR054581A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE LEVETIRACETAM AND PROCESS FOR PREPARATION
WO2008087367A3 (en) Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same
ATE501644T1 (en) LIQUID FORMULATIONS CONTAINING CAROTINOIDS
EP2153831A4 (en) ANTI-FATIGUE AGENT AND ORAL COMPOSITION COMPRISING EACH ANDROGRAPHOLIDE AS ACTIVE INGREDIENT
PT2459153E (en) Pharmaceutical or cosmetic or dietetic composition for promoting a hair pigmentation effect
NZ596683A (en) A pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppressive action of aggressive agents on the skin using a mixture of catechin and quercetin
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
MX2009003060A (en) Emulsion.
TW200718430A (en) Cosmetic powder
MX2010001693A (en) Sprayable composition containing red vine leaf extract.
WO2008081095A3 (en) Use of gamma-aminobutyric acid as a depigmentation agent
MX2008003422A (en) COMPOSITIONS THAT INCLUDE AT LEAST A NAFTOIC ACID DERIVATIVE AND AT LEAST A POLYURETHANE POLYMER TYPE COMPOSITE OR DERIVATIVES, PREPARATION PROCESSES AND COMPOSITIONS THAT INCLUDE AT LEAST A NAFTOIC ACID DERIVATIVE AND AT LEAST
CL2012003250A1 (en) Use of a galactolipid in combination with ascorbic acid and / or a derivative thereof that serves to protect a composition against oxidation; method for the preparation of the composition, composition; and product.
AR076576A1 (en) PROCEDURE TO STABILIZE A DIETARY SUPPLEMENT TO FACILITATE THE HEALTH OF ARTICULATIONS IN HUMAN BEINGS
WO2008120542A1 (en) Food composition having the form of solid preparation comprising plant polygonum aviculare as active ingredient
BR112013026564A2 (en) use of a combination

Legal Events

Date Code Title Description
FC Refusal